These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2071982

  • 1. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K, Natarajan M, Bagga A, Katoch VM.
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [Abstract] [Full Text] [Related]

  • 2. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
    Katoch K, Ramu G, Ramanathan U, Sengupta U, Sreevatsa, Sharma VD, Shivannavar CT, Katoch VM.
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Sreevatsa, Gupta UD, Sharma VD, Shivanavar CT.
    Vaccine; 2004 Sep 09; 22(27-28):3649-57. PubMed ID: 15315844
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun 09; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME, Alvim MF, Nery JA, Albuquerque EC, Sarno EN.
    Indian J Lepr; 1996 Jun 09; 68(3):235-45. PubMed ID: 8889609
    [Abstract] [Full Text] [Related]

  • 15. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2000 Jun 09; 68(2):129-35. PubMed ID: 11036492
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
    Singh RP, Tiwari VD, Chattopadhyay SP.
    Indian J Lepr; 1993 Jun 09; 65(2):173-80. PubMed ID: 8345231
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.